Lung vascular changes as biomarkers of severity in systemic sclerosis-associated interstitial lung disease

被引:8
|
作者
Bruni, Cosimo [1 ,2 ]
Occhipinti, Mariaelena [3 ]
Pienn, Michael [4 ]
Camiciottoli, Gianna [5 ,6 ]
Bartolucci, Maurizio [7 ]
Bosello, Silvia Laura [8 ]
Payer, Christian [9 ]
Balint, Zoltan [10 ]
Larici, Anna Rita [11 ,12 ]
Tottoli, Alessandra [1 ]
Tofani, Lorenzo [1 ,13 ]
De Lorenzis, Enrico [8 ]
Lepri, Gemma [1 ]
Bellando-Randone, Silvia [1 ]
Spinella, Amelia [14 ]
Giuggioli, Dilia [14 ]
Masini, Francesco [15 ]
Cuomo, Giovanna [15 ]
Lavorini, Federico [5 ,6 ]
Colagrande, Stefano [16 ]
Olschewski, Horst [4 ,17 ]
Matucci-Cerinic, Marco [1 ,18 ]
机构
[1] Azienda Osped Univ Careggi, Dept Expt & Clin Med, Div Rheumatol, Via Oblate 4, I-50141 Florence, Italy
[2] Univ Zurich, Univ Hosp Zurich, Dept Rheumatol, Zurich, Switzerland
[3] Radiomics, Liege, Belgium
[4] Ludwig Boltzmann Inst Lung Vasc Res, Graz, Austria
[5] Univ Florence, Dept Biomed Expt & Clin Sci, Florence, Italy
[6] Careggi Univ Hosp, Dept CardioThoracoVasc, Florence, Italy
[7] Santo Stefano Hosp, Dept Radiol, Prato, Italy
[8] Fdn Policlin Univ A Gemelli IRCCS, Dept Rheumatol, Rome, Italy
[9] Graz Univ Technol, Inst Comp Graph & Vis, Graz, Austria
[10] Babes Bolyai Univ, Fac Phys, Cluj Napoca, Romania
[11] Univ Cattolica Sacro Cuore, Dept Radiol & Hematol Sci, Sect Radiol, Rome, Italy
[12] Fdn Policlin Univ A Gemelli IRCCS, Dept Diagnost Imaging Oncol Radiotherapy & Hemato, Rome, Italy
[13] Univ Florence, Dept Stat Comp Sci Applicat, Florence, Italy
[14] Univ Modena & Reggio Emilia, Azienda Osped Univ Modena, Dept Med & Surg Sci Children & Adults, Scleroderma Unit,Rheumatol Unit, Modena, Italy
[15] Univ Campania L Vanvitelli, Dept Med Precis, Naples, Italy
[16] Univ Florence, Careggi Univ Hosp, Dept Expt & Clin Biomed Sci, Radiodiagnost Unit 2, Florence, Italy
[17] Med Univ Graz, Dept Internal Med, Div Pulmonol, Graz, Austria
[18] IRCCS San Raffaele Hosp, Unit Immunol Rheumatol Allergy & Rare Dis UnIRAR, Milan, Italy
关键词
systemic sclerosis; interstitial lung disease; lung vessels; PULMONARY ARTERIAL-HYPERTENSION; PATHOGENESIS;
D O I
10.1093/rheumatology/keac311
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives It has recently become possible to assess lung vascular and parenchymal changes quantitatively in thoracic CT images using automated software tools. We investigated the vessel parameters of patients with SSc, quantified by CT imaging, and correlated them with interstitial lung disease (ILD) features. Methods SSc patients undergoing standard of care pulmonary function testing and CT evaluation were retrospectively evaluated. CT images were analysed for ILD patterns and total pulmonary vascular volume (PVV) extents with Imbio lung texture analysis. Vascular analysis (volumes, numbers and densities of vessels, separating arteries and veins) was performed with an in-house developed software. A threshold of 5% ILD extent was chosen to define the presence of ILD, and commonly used cut-offs of lung function were adopted. Results A total of 79 patients [52 women, 40 ILD, mean age 56.2 (s.d. 14.2) years, total ILD extent 9.5 (10.7)%, PVV/lung volume % 2.8%] were enrolled. Vascular parameters for total and separated PVV significantly correlated with functional parameters and ILD pattern extents. SSc-associated ILD (SSc-ILD) patients presented with an increased number and volume of arterial vessels, in particular those between 2 and 4 mm of diameter, and with a higher density of arteries and veins of <6 mm in diameter. Considering radiological and functional criteria concomitantly, as well as the descriptive trends from the longitudinal evaluations, the normalized PVVs, vessel numbers and densities increased progressively with the increase/worsening of ILD extent and functional impairment. Conclusion In SSc patients CT vessel parameters increase in parallel with ILD extent and functional impairment, and may represent a biomarker of SSc-ILD severity.
引用
收藏
页码:696 / 706
页数:11
相关论文
共 50 条
  • [41] Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
    Cole, Alice
    Denton, Christopher P.
    CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2022, 8 (04) : 152 - 170
  • [42] Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region
    Lescoat, Alain
    Huscher, Doerte
    Schoof, Nils
    Airo, Paolo
    De Vries-Bouwstra, Jeska
    Riemekasten, Gabriela
    Hachulla, Eric
    Doria, Andrea
    Rosato, Edoardo
    Hunzelmann, Nicolas
    Montecucco, Carlomaurizio
    Gabrielli, Armando
    Hoffmann-Vold, Anna-Maria
    Distler, Oliver
    Ben Shimol, Jennifer
    Cutolo, Maurizio
    Allanore, Yannick
    RHEUMATOLOGY, 2023, 62 (06) : 2178 - 2188
  • [43] Tomographic Fibrosis Score in the Patients with Systemic Sclerosis-Associated Interstitial Lung Disease
    Ozmen, Mustafa
    Gumus, Cesur
    Otman, Eda
    Sinci, Kazim Ayberk
    Aysin, Idil Kurut
    Solmaz, Dilek
    Akar, Servet
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2023, 10 (03) : 107 - 113
  • [44] Interstitial Lung Disease in Systemic Sclerosis
    Predrag Ostojic
    Marco Matucci Cerinic
    Richard Silver
    Kristin Highland
    Nemanja Damjanov
    Lung, 2007, 185 : 211 - 220
  • [45] Interstitial lung disease in systemic sclerosis
    Ostojic, Predrag
    Cerinic, Marco Matucci
    Silver, Richard
    Highland, Kristin
    Damjanov, Nemanja
    LUNG, 2007, 185 (04) : 211 - 220
  • [46] Nailfold Videocapillaroscopy Changes Are Associated With the Presence and Severity of Systemic Sclerosis-Related Interstitial Lung Disease
    Caetano, Joana
    Paula, Filipe S.
    Amaral, Marta
    Oliveira, Susana
    Alves, Jose D.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 (03) : E12 - E15
  • [47] STRATUS: A Phase II Study of Abituzumab in Patients With Systemic Sclerosis-associated Interstitial Lung Disease
    Khanna, Dinesh
    Tashkin, Donald P.
    Wells, Athol U.
    Seibold, James R.
    Wax, Stephen
    Vazquez-Mateo, Cristina
    Fleuranceau-Morel, Patricia
    Damian, Doris
    Denton, Christopher P.
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (08) : 1295 - 1298
  • [48] Ongoing clinical trials and treatment options for patients with systemic sclerosis-associated interstitial lung disease
    Khanna, Dinesh
    Tashkin, Donald P.
    Denton, Christopher P.
    Lubell, Martin W.
    Vazquez-Mateo, Cristina
    Wax, Stephen
    RHEUMATOLOGY, 2019, 58 (04) : 567 - 579
  • [49] Systemic sclerosis-associated interstitial lung disease - proposed recommendations for future randomised clinical trials
    Khanna, D.
    Brown, K. K.
    Clements, P. J.
    Elashoff, R.
    Furst, D. E.
    Goldin, J.
    Seibold, J. R.
    Silver, R. M.
    Tashkin, D. P.
    Wells, A. U.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S55 - S62
  • [50] Spontaneous pneumothorax during nintedanib therapy in patients with systemic sclerosis-associated interstitial lung disease
    Sumi, Toshiyuki
    Uehara, Hirofumi
    Tada, Makoto
    Keira, Yoshiko
    Kamada, Koki
    Shijubou, Naoki
    Yamada, Yuichi
    Nakata, Hisashi
    Mori, Yuji
    Chiba, Hirofumi
    RESPIROLOGY CASE REPORTS, 2021, 9 (03):